Picture of Catalyst Pharmaceuticals logo

CPRX — Catalyst Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Brief: Catalyst Pharmaceuticals FY Revenue USD 589 Million Vs. IBES Estimate USD 578.4 Million

Feb 25 (Reuters) - Catalyst Pharmaceuticals FY net income USD 214.3 million.

FY operating income USD 257.8 million

outlook FY revenue USD 615-645 million

Recent news on Catalyst Pharmaceuticals

See all news